Cancer screening resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
===Cervical Cancer===
===Cervical Cancer===
*Cervical cancer screening starts at the age of 21 regardless of the onset of sexual activity via Papanicolaou test (Cervical cytology).<ref name="urlRecommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce">{{cite web |url=https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening |title=Recommendation: Cervical Cancer: Screening &#124; United States Preventive Services Taskforce |format= |work= |accessdate=}}</ref>
*Cervical cancer screening starts at the age of 21 regardless of the onset of sexual activity via Papanicolaou test (Cervical cytology).<ref name="urlRecommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce">{{cite web |url=https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening |title=Recommendation: Cervical Cancer: Screening &#124; United States Preventive Services Taskforce |format= |work= |accessdate=}}</ref>
*According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, cervical cancer ranks fourth for both incidence and mortality.<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593  }} </ref>
*According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, [[cervical cancer]] ranks fourth for both incidence and mortality among females.<ref name="pmid30207593">{{cite journal| author=Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A| title=Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | journal=CA Cancer J Clin | year= 2018 | volume= 68 | issue= 6 | pages= 394-424 | pmid=30207593 | doi=10.3322/caac.21492 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30207593  }} </ref>
To view the detailed information on cervical cancer screening [[Cervical cancer screening|click here]].


===Colorectal Cancer===
===Colorectal Cancer===

Revision as of 18:27, 3 August 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]

Overview

This section provides a short and straight to the point overview of the disease or symptom. The first sentence of the overview must contain the name of the disease.

Common Cancers

Breast Cancer

  • Breast cancer screening starts at age ..... via [imaging].
  • To view the detailed information on breast cancer screening click here.

Cervical Cancer

  • Cervical cancer screening starts at the age of 21 regardless of the onset of sexual activity via Papanicolaou test (Cervical cytology).[1]
  • According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, cervical cancer ranks fourth for both incidence and mortality among females.[2]

To view the detailed information on cervical cancer screening click here.

Colorectal Cancer

Endometrial Cancer

Esophageal Cancer

Lung Cancer

  • Lung cancer screening starts among asymptomatic adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit smoking within the past 15 years.[4]
  • According to the GLOBOCAN 2018 estimates of cancer incidence, mortality, and prevalence, Lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths).[2]

Recommendations for lung cancer screening:[4]

Recommended test
  • Low-dose chest CT
Recommended Interval
  • Annual screening (every year)
Age for screening
  • 55-80
Eligibility for screening based on smoking history
  • Patient has 30 or greater than 30-pack-year smoking history and patient is a current smoker or quite smoking within the last 15 years.
Discontinuation of screening
  • Age greater than 80 or
  • Patient successfully quit smoking for 15 years and beyond or
  • Patient has other medical problems that significantly limit life expectancy or ability/willingness to undergo lung cancer surgery.

Ovarian cancer

Prostate Cancer

  1. "Recommendation: Cervical Cancer: Screening | United States Preventive Services Taskforce".
  2. 2.0 2.1 2.2 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018). "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries". CA Cancer J Clin. 68 (6): 394–424. doi:10.3322/caac.21492. PMID 30207593.
  3. US Preventive Services Task Force. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW; et al. (2016). "Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (23): 2564–2575. doi:10.1001/jama.2016.5989. PMID 27304597.
  4. 4.0 4.1 "Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce". Retrieved 8/3/2020. Check date values in: |accessdate= (help)